We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ortho-Clinical Diagnostics, Inc. Announces Availability of HTLV-I/II Assay

News   Mar 30, 2012

 
Ortho-Clinical Diagnostics, Inc. Announces Availability of HTLV-I/II Assay
 
 
Advertisement
 

RELATED ARTICLES

First Comprehensive Review of COVID-19's Effects Outside the Lung Published

News

The first extensive review of COVID-19's effects on all affected organs outside the lungs has been published in Nature Medicine, by researchers from Columbia University.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients

News

A research group has discovered that the concentration of lopinavir and hydroxychloroquine in the lungs of COVID-19 patients is not sufficient to fight the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE